View Document Preview and Link Document Date: 2009-02-09 05:24:20 Open Document File Size: 934,55 KB Share Result on Facebook
Company Cambridge University Press / No. 5823194 / CVS / Sequenom / / Country United Kingdom / Wales / / Currency GBP / / Facility Royal College of Physicians / Royal College of Pathologists / / IndustryTerm clinical applications / non-clinical applications / cffDNA technology raise / cffDNA technology might / wider / fetal carrier status / cffDNA technology / healthcare systems / clinical genetics services / riskier technologies / clinical protocols / prenatal test technology / cffDNA-based technology / boundless applications / potential applications / technology interfaces / technologies technology / cffNA technology raise / pregnancy management / antenatal services / expert medical services / test technology / specialist clinical genetics services / / MedicalCondition Patau’s syndrome / Down’s syndrome / autosomal recessive diseases / congenital adrenal hyperplasia / certain endocrine disorders / specific disorders / X-linked disease / serious medical diseases / Huntingdon’s disease / autosomal dominant diseases / miscarriage / achondroplasia / cystic fibrosis / single gene disorders / sex-linked disease / autosomal recessive disorders / / MedicalTreatment invasive procedures / clinical protocols / / Organization Cambridge University / Alison Hall PHG Foundation Adam Bostanci Stephen John Hughes Hall Centre for Biomedical Science / Foundation for Genomics and Population Health / Royal College of Physicians / PHG Foundation / British Society for Human Genetics / Royal College of Pathologists / NHS / Joint Committee on Medical Genetics / / Person Adam Bostanci Stephen John / / Position cell-free fetal DNA technologies Executive / existing specialist / non-invasive prenatal diagnosis Executive / / Technology Genomics / 7.0 Using technology / cell-free fetal DNA technologies / diagnostic tests / cffDNA-based technology / The technology / cffDNA technology / prenatal test technology / alternative / riskier technologies / cell-free fetal DNA technology / test technology / free-fetal DNA technologies / genome-based technologies / technology The technology / cell-free fetal DNA technologies technology / / URL http / SocialTag 
Ethical, legal and social issues arising from cell-free fetal DNA technologies Appendix III to the report: Cell-free fetal nucleic acids for non-invasive prenatal diagnosis